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Abstract Deletion and mutational analyses of the gastrin
promoter have identified a binding site for the yeast transcription
factor RAP1 relevant for transcriptional activation in islet cells.
We here report that the mammalian transcription factors binding
to this site in islet cells are the Sp transcription factor members
Sp1 and Sp3. Furthermore, functional analyses revealed Sp1-
and Sp3-mediated transcriptional activation of gastrin. These
data reveal that the zinc finger proteins Sp1 and Sp3 do have
similar binding specificities as the multifunctional yeast RAP1
protein.
z 1997 Federation of European Biochemical Societies.
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1. Introduction
RAP1 is a highly abundant multifunctional DNA-binding
protein which e¡ects both transcriptional activation and si-
lencing in yeast dependent on the context of the promoter.
RAP1 also binds to autonomously replicating sequences and
telomeres of yeast chromosomes to regulate cell division [1^3].
Gene regulation is highly conserved between yeast and mam-
malian cells. We recently reported that the rat gastrin pro-
moter contains a yeast RAP1-binding site within the cis-reg-
ulatory domain GRD (gastrin regulatory domain) controlling
gastrin gene transcription in islet cells [4]. Point mutations in
the rat gastrin RAP1-binding site abolished RAP1 binding
and decreased transcriptional activation. Recent data sug-
gested that the CACC box in the human gastrin promoter,
corresponding to the RAP1 site in the rat gastrin promoter, is
also critical for gastrin activation in islet cells [5]. Further-
more, DNA^protein-binding analyses revealed a DNA-bind-
ing activity with RAP1-like binding speci¢city in islet cells,
suggesting a mammalian homologue RAP1-like protein [4].
Gastrin presents an oncofetal expression pattern in islet cells.
The underlying molecular mechanisms of gastrin reexpression
in transformed islet cells are, however, still unknown. There-
fore, transcriptional activators binding to the islet regulatory
domain (GRD) could be pathogenetically relevant. This paper
reports that the RAP1-like binding activity in islet cells is
zinc-dependent and corresponds to the mammalian zinc ¢nger
proteins Sp1 and Sp3, members of a multigene family of GC
box binding proteins with similar structural features [6]. Fur-
thermore, cotransfection experiments revealed Sp1- and Sp3-
mediated transcriptional activation, dependent on the RAP1-
binding site. These data suggest that Sp1 and Sp3 are the two
mammalian proteins acting through the RAP1 site of the
gastrin promoter.
2. Materials and methods
2.1. Gastrin reporter gene construction
The 1300 gastrin reporter gene construct hugas1300 was created by
subcloning the EcoRI^PstI fragment of the human gastrin gene (1300
bp of 5P-£anking DNA and the ¢rst exon) into the promoterless
luciferase vector pGL2-basic (Promega). Deletion constructs hu-
gas119WT and hugas119mt were created using the polymerase chain
reaction (PCR) and the hugas1300 construct as template. The hugas
119mt construct contains a single point mutation in the RAP1-bind-
ing site as described [4]. Cohesive ends were generated on the PCR
products by restriction digest before ligation into the pGL2-basic
vector. Correct insertion was veri¢ed by dideoxy sequencing.
2.2. Cell culture and DNA transfection
Rat insulinoma RIN38A and RINB6 cells were cultured as de-
scribed [7,8]. Schneider cells SL2 [9] were maintained in Schneider
medium supplemented with 10% FCS at 25³C. One day prior to trans-
fection, cells were plated in a mixture of Schneider/DE22 medium
(1:3, supplemented with 10% FCS) onto 6 cm plastic dishes at a
density of 4U10
6
cells/plate and transfected by the calcium phosphate
method described [10]. Each plate received 8 Wg of hugas reporter
construct, 50 ng of either expression plasmid pPac, pPacSp1, pPacSp3
or pPacSp4 [11] and 4 Wg of L-galactosidase expression plasmid p97b
as internal reference [11]. Variable amounts of expression plasmids
were compensated for with the plasmid pPac. Twenty-four hours after
addition of DNA the medium was replaced by Schneider medium and
24 h later cells harvested. Luciferase activity was normalized to L-
galactosidase activity for plate-to-plate variations in transfection e¤-
ciency.
2.3. Bacterial and nuclear extracts
Sp3 cDNA expression plasmids pET-3c/Sp3r (cDNA sense orienta-
tion) or pET-3c/Sp3f (cDNA inverted oritentation) were transformed
into E. coli BL21 (LysS), grown and expression induced with IPTG as
described [12]. Bacterial extracts containing recombinant protein were
prepared according to Kadonaga et al. [13]. Recombinant Sp1 was
purchased (Promega). Nuclear extracts from cell lines were prepared
by a modi¢ed method of Dignam [4]. Protein concentration of the
extract was measured by the Bradford procedure [14].
2.4. Electrophoretic mobility shift assays (EMSA)
Single-stranded oligonucleotides were labeled with [
32
P]ATP using
T4 DNA kinase, hybridized with the complementary strand and pur-
i¢ed by NucTrap Push Column (Stratagene). Sense oligonucleotides
used in this study were (hCACC) -114 GTGACCCCACCCCATTP-
97, rGRDWT -110 CCACACCCATTTCTCTCGCTGTGGGAGT-
CTG -78, RAP1 -112 CTCCACACCCATTTCTC -86. Binding reac-
tions using nuclear cell extracts were performed as described [4]. Poly-
clonal rabbit antisera against Sp1 and Sp3 proteins were generated
using bacterially expressed Sp1 and Sp3 proteins as described [6,11].
Antibodies were added to the binding assay mixture 30 min before
addition of radiolabeled probe.
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2.5. DNase I protection experiments
A DNA fragment spanning nucleotides 3201 to +35 of the human
gastrin promoter was generated by PCR using endlabeled sense oli-
gonucleotide 5P-AACTCCCCTATCCTTCCC-3P, unlabelled antisense
oligonucleotide 5P-CTGCAGAGCTGGGAGGTG-3P and the hu-
gas1300 construct as a template. The probe (30 000 cpm) was mixed
with 50 ng of puri¢ed Sp1 (Promega) or 10 Wg of bacterial extracts in
a bu¡er as described [11]. DNase I (0.1 U) was added, incubated for
60 s at 20³C prior to terminating the reaction. After phenol extraction
and ethanol precipitation, DNA fragments were resolved on a 6%
denaturing polyacrylamide gel. G and G+A sequencing reactions
were performed as described [15].
3. Results
3.1. Binding of Sp1-related proteins to the RAP1 site in the rat
gastrin promoter
An EMSA using the nuclear islet cell extracts and the rat
GRD (rGRDWT) sequence containing the RAP1-binding site
as probe revealed that RAP1-like binding activity, corre-
sponding to complex C1 [4] was zinc-dependent (Fig. 1A).
Although the RAP1 site does not contain the classic Sp1
consensus sequence, Sp1 is capable of recognizing many
GC-rich divergent sequences including GT boxes and CACC
motifs [16^18]. To investigate whether Sp1 was a component
of RAP1-binding activity, we performed EMSAs using islet
nuclear extracts and the RAP1 recognition site sequence as
the probe (RAP1) in the presence or absence of antibody
raised against bacterially expressed Sp1 [11] (Fig. 1B). Com-
petition experiments revealed that complex C1 formation is
dependent on an intact RAP1 binding site (data not shown).
Addition of Sp1 antiserum resulted in a lower migrating
supershifted complex (SS) and revealed complex C1 as a com-
position of at least two retarded bands, the major band cor-
responding to Sp1 (Fig. 1B, lanes 2 and 3). Addition of anti-
serum against Sp3, with identical binding characteristics as
Sp1, resulted in the shift of a weak migrating complex (Fig.
1B, lanes 4 and 5). Combined addition of Sp1 and Sp3 anti-
sera resulted in a high molecular weight supershifted complex
that could not migrate into the gel (Fig. 1B, lane 6), while the
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Fig. 1. Sp1 and Sp3 bind to the RAP1 element in the rat gastrin promoter. A: EMSA was performed using nuclear extracts of RIN B6 cells
and the end-labelled rGRD sequence as probe. Complex formation C1 corresponding to RAP1-like binding activity in islet cells is dependent
on the presence of 1.0 mM or absence (3) of ZnCl
2
, suggesting binding of zinc ¢nger protein (s). The other complexes formed are RAP1 inde-
pendent [4]. B: Identi¢cation of Sp1 and Sp3 as components of RAP1-like binding activity. EMSAs were performed using RIN38A nuclear ex-
tracts and the RAP1-binding site as the labelled probe. Antisera against Sp1 (KSp1; lanes 3 and 6), against Sp3 (KSp3; lanes 5 and 6), against
Sp4 (KSp4; lane 8), and appropriate pre-immune sera (pre; lanes 2, 4 and 7) were included into the binding reactions as indicated above each
lane. Supershifted complexes are indicated SS. C, DNA^protein complex formation; F, free migrating probe.
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faster migrating Sp3 complex and the major part of complex
C1 disappeared. Addition of Sp4 antiserum revealed no gross
change of any complex (Fig. 1B, lanes 7 and 8) except a faint
supershifted complex comigrating with supershifted Sp1.
These ¢ndings suggest that the major part of RAP1 binding
consists of Sp1 and to a lesser extent of Sp3. A potential third
protein comigrating in complex C1 remains to be identi¢ed.
The Sp3 complex might re£ect binding of the 58 kDa or/and
60 kDa Sp3 polypeptides, while the 97 kDa Sp3 polypeptide is
suggested to comigrate in complex C1 [11]. The islet proteins
involved in the indicated faster migrating complexes C also
represent binding activities dependent on an intact RAP1-
binding site, although their nature remains to be determined.
3.2. Sp1 and Sp3 as components binding to the CACC element
in the human gastrin promoter
The CACC element in the human gastrin promoter corre-
sponds to the RAP1 site in the rat promoter and revealed
RAP1-like binding speci¢city [4,5]. EMSA demonstrated a
major speci¢c zinc-dependent binding activity in islet cells to
the CACC element (data not shown), indicated here as com-
plex A. Binding of Sp1-related proteins was immunologically
analyzed in an EMSA using islet nuclear extracts and the
CACC element as the probe. Addition of Sp1 antiserum re-
sulted in a supershifted complex ss (Fig. 2, lanes 2 and 3) with
concomitant absence of the major part of complex A, suggest-
ing Sp1 binding. In the presence of Sp3 antiserum, a weak
complex (lanes 6 and 7) corresponding to Sp3 was shifted.
Combined addition of Sp1 and Sp3 antisera resulted in a
high molecular mass complex not entering the gel (lane 9),
while the Sp3 complex and complex A were shifted. While
addition of Sp4 antiserum revealed no gross changes in com-
plex formation (lanes 10 and 11), a weak complexed band (ss,
right site) became visible comigrating with shifted Sp1, that
could result from a small amount of supershifted Sp4,
although this has to be further investigated. Therefore, Sp1
and Sp3 also bind to the CACC element with Sp1 constituting
the major binding component.
3.3. The proximal human gastrin promoter contains three
binding sites for members of the Sp transcription factor
family
To delineate binding sites for Sp proteins in the proximal
human promoter, recombinant Sp1 and Sp3 proteins were
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Fig. 2. Sp1 and Sp3 are components binding to the CACC element in the human gastrin promoter. EMSA were performed using RIN38A nu-
clear extracts and the human CACC/RAP1 site as labelled probe. Antisera against Sp1 (KSp1; lanes 3, 5 and 9), against Sp3 (KSp3; lanes 7
and 9), against Sp4 (KSp4; lane 11), and appropriate pre-immune sera (pre; lanes 2, 4, 6, 8 and 10) were included in the binding reactions as
indicated above each lane. Supershifted complexes are indicated SS. NE, nuclear extracts; A, DNA^protein complex; F, free migrating probe.
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Fig. 3. DNase I protection of the CACC/RAP1-like element in the human gastrin promoter by recombinant Sp1 and Sp3. A: Reactions were
performed on the coding strand of 201 bp of 5P £anking sequence of the gastrin promoter. The labeled DNA fragments were DNase I digested
in the absence (3) or presence (+) of recombinant Sp1 (Sp1), Sp3 (Sp3R) or extracts produced with a Sp3 cDNA in inverse orientation
(Sp3F). Alongside the autoradiographs protected regions are boxed and indicated I3III, numbers refer to the positions relative to the transcrip-
tion start site. G and G+A refer to Maxam Gilbert sequencing reactions. B: Schematic representation of Sp-binding sites in the gastrin pro-
moter context. I^III refer to the protected sequences as demonstrated in (A).
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tested for binding in a DNase I footprint experiment. A DNA
fragment spanning nucleotides 3201 to +35 was incubated
with puri¢ed Sp1 or Sp3, subjected to partial DNase I diges-
tion and analyzed (Fig. 3A). Addition of Sp1 revealed three
distinct regions (I^III) of nuclease protection, each binding
site covering 12^19 bp and centered around a single GC
rich sequence (sites I and III) and the CACC element/
RAP1-binding site (site II) as shown in Fig. 3A (lane 4).
Sp3 essentially revealed an identical protection pattern except,
that only a weak protection was detected at site I (Fig. 3A,
lanes 5 and 6). No binding was observed with a Sp3 expres-
sion construct in inverse orientation (Fig. 3A, lane 7). The
localization of the Sp-binding sites in the proximal gastrin
promoter are summerized in Fig. 3B. Site I corresponds to
the 5P part of the EGF response element gERE [19]. Site II
corresponds to the CACC- or RAP1-binding site, while
site III was suggested to confer cAMP response synergistically
with site I in GH4 cells [20]. These data con¢rm binding of
both, Sp1 and Sp3 bind to the RAP1-like site (CACC ele-
ment) in the human gastrin promoter.
3.4. Sp1- and Sp3-mediated transcriptional activation depends
on the RAP1-binding site
Deletional analyses suggested that the RAP1/CACC ele-
ment in the human gastrin promoter is a positive regulatory
element [5]. Functional activity of transfected Sp1 cannot be
studied unambiguously in islet cells, since they contain endog-
enous Sp proteins. To determine whether Sp1 and Sp3 act as
transcriptional regulators binding to the RAP1 element, we
performed gene transfer experiments into Drosophila mela-
nogaster Schneider cells (SL2) that lack endogenous Sp factors
[9]. Luciferase reporter constructs contained the intact gastrin
5P-£anking sequence spanning 119 bp including the ¢rst exon.
A mutant reporter construct hugas119mt contained a single
base pair mutation critical for RAP1-like binding [4,5]. Re-
porter constructs were transfected into SL2 cells along with
one of the expression plasmids pPacSp1, pPacSp3, pPacSp4 or
pPac. Expression was con¢rmed using a BCAT-2 construct
containing two Sp1-binding sites in tandem array from the
HTLV-III promoter ([10], data not shown). The hugas119
intact reporter construct comprising two binding sites for
Sp1 was activated 3-fold by cotransfected Sp1, while Sp1 co-
transfection only revealed a minor e¡ect on the mutant hu-
gas119mt reporter construct (Fig. 4). This result suggested
that Sp1-mediated transcriptional activation was mainly due
to the intact RAP1 element. The weak transcriptional activa-
tion of the hugas119mt reporter construct is due to the intact
Sp1-binding site I of the gERE element, since further deletion
of this site completely prevented Sp1-mediated activation
(data not shown). Coexpression of Sp3 revealed a 2.4-fold
induction of transcription using the hugas119, while only a
slight increase was observed using the mutant hugas119mt
reporter construct. Combined cotransfection of Sp1 and Sp3
revealed an almost 7-fold increase in transcriptional activation
of the intact reporter plasmid hugas119. In contrast, only a
slight increase of promoter activity was observed using the
mutant reporter construct hugas119mt. Cotransfection of
Sp4 revealed no transcriptional e¡ect on either promoter con-
struct. These data demonstrate, that both, Sp1 and Sp3 acti-
vate gastrin gene transcription, while Sp4 has no e¡ect. Fur-
thermore, Sp1- and Sp3-mediated transcriptional activation
was dependent on an intact RAP1-binding site, supporting
the DNA^protein binding analyses.
4. Discussion
Previous studies have identi¢ed a yeast RAP1-binding site
within the GRD cis-regulatory sequence of the rat and human
gastrin promoter [4]. Detection of a RAP1-like binding activ-
ity confering transcriptional activation of the gastrin pro-
moter in islet cells suggested a mammalian transcription fac-
tor with similar binding speci¢city like yeast RAP1 [4,5]. Here,
we report that Sp1 and Sp3 are components of the RAP1-like
binding activity in islet cells. Furthermore, footprinting anal-
ysis identi¢ed three Sp1-binding sites in the proximal gastrin
promoter (Fig. 3) correponding to the gERE site [19], to the
RAP1 site [4,5] and a cAMP responsive element relevant in
GH4cells [20]. These data are consistent with previous reports
suggesting that Sp1 binding to the 5P part of the gERE site
[19] and to the cAMP response element further upstream of
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Fig. 4. E¡ect of Sp1 and Sp3 expression on gastrin promoter activity. SL2 cells were transiently cotransfected with 8 Wg of gastrin reporter de-
letion construct hugas119 or the construct hugas119mt, containing a single point mutation in the RAP1-binding site [4], 50 ng of the expression
plasmids pPacSp1, pPacSp3, pPacSp4 or vector pPac [11] and 4 Wg of L-galactosidase expression plasmid p97b as internal reference. Combined
cotransfection was performed with 50 ng of each expression plasmid. Variable amounts of expression plasmids were compensated for with the
plasmid pPac. Luciferase activity was normalized to L-galactosidase activity for plate to plate variations in transfection e¤ciency.
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the RAP1 site [20^22]. Moreover, protection by Sp3 was ob-
served at the RAP1-binding site and cAMP response element,
and to a minor extent at the gERE site. Weak protection by
Sp3 could be due to lower concentrations of recombinant Sp3
protein or the fact, that the Sp3 recombinant protein is not
full-length in contrast to the Sp1 protein. The in vitro DNA^
protein binding data correlated with the functional results. We
here report Sp1- and Sp3-mediated activation of the gastrin
promoter that was dependent on the functional RAP1 site.
Sp1 activation is a complex mechanism involving not only
protein^DNA interactions, but also interaction of multiple
modular domains of Sp1 with coactivator proteins [23,24].
Arti¢cial and cellular promoters are di¡erentially responsive
to Sp3. Sp3 is believed to repress transcriptional activation of
viral promoters, most likely by competing with Sp1 for the
binding site [11,12,25]. Functional analysis using endogenous
cellular promoters revealed Sp3-mediated repression of Sp1
activation dependent upon the promoter context and/or num-
ber of functional Sp1-binding sites. Thus, single GC boxes
within the histone H4 or TK promoters which confer tran-
scriptional activation via Sp1 binding were not responsive to
repression by Sp3, while Sp1-mediated activation of the
DHFR promoter, containing multiple functional G/C boxes
was strongly repressed by Sp3 [26]. Sp3 also activates the
histone H4 promoter signi¢cantly [26]. Sp3 may also activate
some promoter fragments containing an RCE (retinoblastoma
control element) [27]. Arti¢cial reporter constructs with multi-
merized elements omitting adjacent regulatory elements ap-
pear not suitable for promoter studies since activation and
repression occur in a promoter context-dependent manner.
We performed the functional studies with an intact gastrin
promoter construct comprising 119 bp upstream the TATA
box including a single RAP1 site. The presence of a single
RAP1-binding site, instead of arti¢cial multimerized binding
elements, could explain the non-responsiveness to the repres-
sor function of Sp3. The activator and inhibitor function of
Sp3 reside in di¡erent parts of the protein. Therefore, the
transcriptional activity of Sp3 might be regulated in vivo by
relief of inhibition [28], suggesting that the promoter context
is important for Sp3 function. Binding analysis suggested that
an additional protein is involved in RAP1-like binding activ-
ity, since a weak DNA^protein complex remained after the
combined Sp1 and Sp3 supershift. This binding activity may
correspond to the 70 kDa reported by Tillotson [5] since this
protein appears to be a zinc ¢nger protein with binding spe-
ci¢city di¡erent from Sp1 and Sp3. A complete de¢nition of
the role of Sp1 and Sp3 in gastrin transcription, however,
clearly awaits a more detailed mutational analysis of this pro-
moter. Many studies have shown that yeast and mammalian
transcription factors share functional and structural features.
Interestingly, besides the binding speci¢city, Sp3 and the yeast
RAP1 protein can function both, as activators and repressors
of transcription, are context-dependent regulatory proteins
and contain discrete silencing and activation domains apart
from their DNA-binding sites [1^3,6,11,12,28]. Protein^pro-
tein interactions most likely control their diverse regulatory
functions. Taken together, the RAP1-like binding activity in
islet cells corresponds to the mammalian transcription factors
Sp1 and Sp3, that share common features with the yeast
RAP1 protein.
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